Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about aco2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Gene Symbol | ACO2 |
| Full Name | Aconitase 2 |
| Chromosome | 22q13.2 |
| Protein Type | Enzyme |
| Function | is a mitochondrial enzyme that catalyzes the stereospecific isomerization of citrate to isocitrate via cis-aconitate in the second step of the tricarboxylic acid (TCA) cycle[@beinert1996]. |
| Primary Expression | all nucleated cells: |
| Amino Acids | 778 aa |
| Exons | 18 |
| Ensembl ID | ENSG00000100412 |
| GeneCards | ACO2 |
| Human Protein Atlas | ACO2 |
| Four functional domains | Organized around the 4Fe-4S cluster |
| 4Fe-4S cluster binding site | Essential for catalytic activity and redox sensing |
| Active site | Contains three conserved cysteine residues coordinating the iron-sulfur cluster |
| Citrate → cis-Aconitate → Isocitrate | Stereochemical isomerization |
| Associated Diseases | neurodegeneration |
| Interactions | ATP, ATP5A1, CYCS, GLUD1, HSPA9, IMMUNE INFILTRATION |
| KG Connections | 82 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
ACO2["ACO2"]
ACO2 -->|"involved_in"| TCA_Cycle["TCA Cycle"]
ACO2 -.biomarker for.-> Parkinson_S_Disease["Parkinson'S Disease"]
ACO2 -->|"target for"| Parkinson["Parkinson"]
ACO2 -->|"target for"| GLUD1["GLUD1"]
ACO2 -->|"expressed in"| SNCA["SNCA"]
ACO2 -->|"target for"| LRPPRC["LRPPRC"]
ACO2 -->|"target for"| OXIDATIVE_STRESS["OXIDATIVE STRESS"]
PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"target for"| ACO2
VDAC1["VDAC1"] -->|"expressed in"| ACO2
HSPA9["HSPA9"] -->|"expressed in"| ACO2
CYCS["CYCS"] -->|"expressed in"| ACO2
IMMUNE_INFILTRATION["IMMUNE INFILTRATION"] -->|"target for"| ACO2
OXIDATIVE_STRESS -->|"target for"| ACO2
GENES["GENES"] -->|"target for"| ACO2
SNCA -->|"expressed in"| ACO2| Target | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:ACO2 | data_in | dataset_row | 0.00 |
| TCA Cycle | involved_in | pathway | 0.82 |
| Parkinson'S Disease | biomarker_for | disease | 0.75 |
| Parkinson | activates | disease | 0.65 |
| Parkinson | therapeutic_target | disease | 0.65 |
| PARKINSON'S DISEASE | therapeutic_target | gene | 0.60 |
| PARKINSON | therapeutic_target | gene | 0.60 |
| T Cell | therapeutic_target | cell_type | 0.60 |
| Neuron | therapeutic_target | cell_type | 0.60 |
| HUB GENES | associated_with | gene | 0.60 |
| OXIDATIVE STRESS | activates | gene | 0.60 |
| ROS | activates | gene | 0.60 |
| ATP | activates | gene | 0.60 |
| PARKINSON'S DISEASE | activates | gene | 0.60 |
| IMMUNE INFILTRATION | activates | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| PARKINSON | activates | gene | 0.60 |
| Oxidative Phosphorylation | activates | pathway | 0.60 |
| Oxidative Stress | activates | pathway | 0.60 |
| CACNA1A | regulates | gene | 0.60 |
| Oxidative Phosphorylation | therapeutic_target | pathway | 0.60 |
| Oxidative Stress | therapeutic_target | pathway | 0.60 |
| ROS | therapeutic_target | gene | 0.60 |
| AND | expressed_in | gene | 0.60 |
| CYCS | associated_with | gene | 0.60 |
| HSPA9 | associated_with | gene | 0.60 |
| SDHA | associated_with | gene | 0.60 |
| SNCA | associated_with | gene | 0.60 |
| VDAC1 | associated_with | gene | 0.60 |
| ATP5A1 | interacts_with | gene | 0.60 |
| MDH2 | interacts_with | gene | 0.60 |
| NDUFS3 | interacts_with | gene | 0.60 |
| PDHB | interacts_with | gene | 0.60 |
| SDHA | interacts_with | gene | 0.60 |
| SUCLG1 | interacts_with | gene | 0.60 |
| OXIDATIVE STRESS | therapeutic_target | gene | 0.60 |
| ATP | therapeutic_target | gene | 0.60 |
| App | therapeutic_target | protein | 0.60 |
| neurons | expressed_in | cell_type | 0.60 |
| GLUD1 | therapeutic_target | gene | 0.60 |
| SNCA | expressed_in | gene | 0.60 |
| LRPPRC | therapeutic_target | gene | 0.60 |
| NDUFS2 | therapeutic_target | gene | 0.60 |
| NDUFS1 | therapeutic_target | gene | 0.60 |
| SDHA | expressed_in | gene | 0.60 |
| VDAC1 | expressed_in | gene | 0.60 |
| CYCS | expressed_in | gene | 0.60 |
| HSPA9 | expressed_in | gene | 0.60 |
| NDUFS1 | activates | gene | 0.60 |
| NDUFS2 | activates | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:ACO2 | data_in | dataset_row | 0.00 |
| genes-aco2 | describes | wiki_page | 0.95 |
| ATP | therapeutic_target | gene | 0.60 |
| ROS | therapeutic_target | gene | 0.60 |
| PARKINSON | therapeutic_target | gene | 0.60 |
| VDAC1 | expressed_in | gene | 0.60 |
| HSPA9 | expressed_in | gene | 0.60 |
| CYCS | expressed_in | gene | 0.60 |
| SNCA | expressed_in | gene | 0.60 |
| NDUFS1 | therapeutic_target | gene | 0.60 |
| LRPPRC | therapeutic_target | gene | 0.60 |
| SDHA | expressed_in | gene | 0.60 |
| LRPPRC | activates | gene | 0.60 |
| GLUD1 | activates | gene | 0.60 |
| GLUD1 | therapeutic_target | gene | 0.60 |
| NDUFS2 | therapeutic_target | gene | 0.60 |
| PARKINSON'S DISEASE | therapeutic_target | gene | 0.60 |
| OXIDATIVE STRESS | therapeutic_target | gene | 0.60 |
| IMMUNE INFILTRATION | therapeutic_target | gene | 0.60 |
| GENES | therapeutic_target | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning aco2 in their description or question text
No additional research found